Ariad Pharmaceuticals Inc fka ARIA

[chazzzzz]

Don, even though the company may have enough cash to last thru the better half of next year, the perfect scenario would be if the RIDA analysis came positive. Of Course the stock would rise and then the company would be able to go the market and sell equity. Even though there would be dilution, 10 million shares @ $7.00 would pretty much cover AP534 without much partnering.

Even though we think that AP534 is the key to the future, I think that RIDA's analysis is key to the future of the Ap534 and its timeliness to market.